Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study
Status:
COMPLETED
Trial end date:
2025-05-16
Target enrollment:
Participant gender:
Summary
This is a double-blind, placebo-controlled, randomized two-phase study to evaluate the safety and pharmacokinetics (PK) of two TAF/EVG inserts administered rectally for 3 consecutive days, then every other day for 14 days.
Phase:
PHASE1
Details
Lead Sponsor:
Eastern Virginia Medical School
Collaborators:
Centers for Disease Control and Prevention CONRAD Emory University